| 2023 | Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19-14) | LANCET GASTROENTEROLOGY & HEPATOLOGY |
| 2023 | Outcomes of an Acute Palliative Care Unit at a Comprehensive Cancer Center in Korea
| PALLIATIVE MEDICINE REPORTS |
| 2022 | Enhanced tumor targeting and timely viral release of mesenchymal stem cells/oncolytic virus complex due to GRP78 and inducible E1B55K expressions greatly increase the antitumor effect of systemic treatment
| MOLECULAR THERAPY-ONCOLYTICS |
| 2022 | The presence and size of intrahepatic tumors determine the therapeutic efficacy of nivolumab in advanced hepatocellular carcinoma
| THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY |
| 2022 | Activated TAZ induces liver cancer in collaboration with EGFR/HER2 signaling pathways
| BMC CANCER |
| 2022 | Phase II study of gemcitabine with oxaliplatin (GEMOX) in heavily treated patients with advanced hepatocellular carcinoma after failure of sorafenib treatment (PEACH) | JOURNAL OF CLINICAL ONCOLOGY |
| 2022 | A multi-institutional, single-arm, phase II trial of neoadjuvant modified-FOLFIRINOX for resectable pancreatic ductal adenocarcinoma | JOURNAL OF CLINICAL ONCOLOGY |
| 2021 | Early Diagnostic Ability of Human Complement Factor B in Pancreatic Cancer Is Partly Linked to Its Potential Tumor-Promoting Role | JOURNAL OF PROTEOME RESEARCH |
| 2021 | Molecular Characterization of Biliary Tract Cancer Predicts Chemotherapy and Programmed Death 1/Programmed Death-Ligand 1 Blockade Responses | HEPATOLOGY |
| 2021 | Phase 2 study of TAS-117, an allosteric akt inhibitor in advanced solid tumors harboring phosphatidylinositol 3-kinase/v-akt murine thymoma viral oncogene homolog gene mutations
| INVESTIGATIONAL NEW DRUGS |
| 2021 | Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2021 | Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis
| THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY |
| 2021 | Adjuvant radiotherapy and chemotherapy offer a recurrence and survival benefit in patients with resected perihilar cholangiocarcinoma | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2021 | Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpression | BRITISH JOURNAL OF CANCER |
| 2021 | Expression of Organic Anion Transporting Polypeptides in an H-Ras 12V Transgenic Mouse Model of Spontaneous Hepatocellular Carcinoma
| YONSEI MEDICAL JOURNAL |
| 2021 | Systemic Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors in Korea: Literature Review and Expert Opinion
| CANCER RESEARCH AND TREATMENT |
| 2021 | Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the second-line chemotherapy for patients with metastatic pancreatic cancer: a multicenter retrospective study of the Korean Cancer Study Group (KCSG)
| ESMO OPEN |
| 2021 | Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinoma | JOURNAL OF HEPATOLOGY |
| 2021 | Pilot study for the Psychometric Validation of the Sheffield Profile for Assessment and Referral to Care (SPARC) in Korean Cancer Patients
| CANCER RESEARCH AND TREATMENT |
| 2021 | Enhanced oncolytic adenoviral production by downregulation of death-domain associated protein and overexpression of precursor terminal protein
| SCIENTIFIC REPORTS |
| 2020 | Pre-screening of patient-reported symptoms using the Edmonton Symptom Assessment System in outpatient palliative cancer care | EUROPEAN JOURNAL OF CANCER CARE |
| 2020 | Survival, Prognostic Factors, and Volumetric Analysis of Extent of Resection for Anaplastic Gliomas
| CANCER RESEARCH AND TREATMENT |
| 2020 | Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine (a CYP1A2 Substrate) in Patients With BRAF V600 Mutation-Positive Malignancies | CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT |
| 2020 | Human Organic Anion Transporting Polypeptide 1B3 Applied as an MRI-Based Reporter Gene
| KOREAN JOURNAL OF RADIOLOGY |
| 2020 | Phase I study of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with pretreated biliary tract cancer
| JOURNAL FOR IMMUNOTHERAPY OF CANCER |
| 2020 | Efficacy and Safety of Liver-Directed Concurrent Chemoradiotherapy and Sequential Sorafenib for Advanced Hepatocellular Carcinoma: A Prospective Phase 2 Trial | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
| 2020 | Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI-1 study
| CANCER SCIENCE |
| 2020 | Extent of resection and molecular pathologic subtype are potent prognostic factors of adult WHO grade II glioma
| SCIENTIFIC REPORTS |
| 2019 | β-catenin activation down-regulates cell-cell junction-related genes and induces epithelial-to-mesenchymal transition in colorectal cancers
| SCIENTIFIC REPORTS |
| 2019 | Mesothelin Expression Is a Predictive Factor for Peritoneal Recurrence in Curatively Resected Stage III Gastric Cancer | ONCOLOGIST |
| 2019 | Significance of Metabolic Tumor Volume and Total Lesion Glycolysis Measured Using ¹⁸F-FDG PET/CT in Locally Advanced and Metastatic Gallbladder Carcinoma
| YONSEI MEDICAL JOURNAL |
| 2019 | Capecitabine plus oxaliplatin versus gemcitabine plus oxaliplatin as first-line therapy for advanced biliary tract cancers: a multicenter, open-label, randomized, phase III, noninferiority trial | ANNALS OF ONCOLOGY |
| 2019 | Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study Group
| THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY |
| 2019 | High levels of Daxx due to low cellular levels of HSP25 in murine cancer cells result in inefficient adenovirus replication
| EXPERIMENTAL AND MOLECULAR MEDICINE |
| 2019 | Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation
| Cancer Medicine |
| 2019 | An Open-Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM-080301 in Subjects with Advanced Hepatocellular Carcinoma
| Oncologist |
| 2019 | Interprofessional Collaboration Between a Multidisciplinary Palliative Care Team and the Team Pharmacist on Pain Management | AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE |
| 2019 | Distinct immunological properties of the two histological subtypes of adenocarcinoma of the ampulla of Vater | CANCER IMMUNOLOGY IMMUNOTHERAPY |
| 2018 | TGF-β downregulation-induced cancer cell death is finely regulated by the SAPK signaling cascade
| EXPERIMENTAL AND MOLECULAR MEDICINE |
| 2018 | Multiple systemic extraneural metastasis of glioblastoma | CHIRURGIA |
| 2018 | Outpatient Palliative Care and Aggressiveness of End-of-Life Care in Patients with Metastatic Colorectal Cancer | AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE |
| 2017 | Prognostic Factors and Scoring Model for Survival in Metastatic Biliary Tract Cancer
| CANCER RESEARCH AND TREATMENT |
| 2017 | Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis.
| MEDICINE |
| 2017 | Down-Regulation of TGF-β Expression Sensitizes the Resistance of Hepatocellular Carcinoma Cells to Sorafenib.
| YONSEI MEDICAL JOURNAL |
| 2017 | Prime-boost immunization by both DNA vaccine and oncolytic adenovirus expressing GM-CSF and shRNA of TGF-β2 induces anti-tumor immune activation
| ONCOTARGET |
| 2016 | Characteristics of Venous Thromboembolism in Pancreatic Adenocarcinoma in East Asian Ethnics: A Large Population-Based Observational Study
| MEDICINE |
| 2016 | Survivin silencing and TRAIL expression using oncolytic adenovirus increase anti-tumorigenic activity in gemcitabine-resistant pancreatic cancer cells | APOPTOSIS |
| 2016 | Pseudoprogression in glioblastoma patients: the impact of extent of resection | JOURNAL OF NEURO-ONCOLOGY |
| 2015 | Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients Who Failed First-Line Therapy Containing Dacarbazine
| CANCER RESEARCH AND TREATMENT |
| 2015 | Hepatitis B viral load predicts survival in hepatocellular carcinoma patients treated with sorafenib | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
http://orcid.org/0000-0001-5917-1400
(16245321500)
